Journal article

Venetoclax, the First BCL-2 Inhibitor for Use in Patients With Chronic Lymphocytic Leukemia

John Seymour

Clinical advances in hematology & oncology : H&O | MILLENNIUM MEDICAL PUBLISHING, INC | Published : 2019